A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them.


Updates from The Motley Fool

Latest updates on CASI Pharmaceuticals from Fool.com.


Stock Performance

CASI vs. S&P 500 | 2 Year Performance
View Interactive CASI Charts
Sponsored by

Key Data Points

Primary metrics and data points about CASI Pharmaceuticals.
Current Price: $1.15
Prev Close: $1.14
Open: $1.13
Bid: $0.89
Ask: $1.19
Day's Range: $1.13 - $1.15
52wk Range: $0.58 - $1.82
Volume: 7,793
Avg Vol 38,208
Market Cap: $37.31M
P/E (ttm): -5.18
EPS (ttm): -$0.22
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CASI Pharmaceuticals.
CAPS Rating 0 out of 5
 
45 Outperform
13 Underperform
CAPS All Stars
 
7 Outperform
7 Underperform

How do you think CASI Pharmaceuticals will perform against the market?



You pick for CASI Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for CASI Pharmaceuticals.

A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers